Optimise your PCR-based testing infrastructure to meet current and future infectious disease detection needs.
Your partner for every pivot
Scale with ease as needs change.The onset of the COVID-19 global pandemic in early 2020 marked the start of a dramatic pivot in clinical diagnostic assay development, and in patient sample collection and processing. As vaccination programmes roll out, diagnostic assay developers and testing labs need to remain vigilant in accommodating the evolving needs of the public health crisis as well as ongoing demand for patient screening for a wide breadth of conditions.
Throughout the COVID-19 pandemic, Biosearch Technologies demonstrated a unique ability to serve the diagnostic community as a reliable mission-critical component supplier. Explore how we can help your organisation manage today while planning for tomorrow.